testosterone

Trade name: delatestryl

Small moleculeapproved

Approved

Dec 24, 1953

Testosterone is a steroid sex hormone found in both men and women. In men, testosterone is produced primarily by the Leydig (interstitial) cells of the testes when stimulated by luteinizing hormone (LH). It functions to stimulate spermatogenesis, promote physical and functional maturation of spermatozoa, maintain accessory organs of the male reproductive tract, support development of secondary sexual characteristics, stimulate growth and metabolism throughout the body and influence brain development by stimulating sexual behaviors and sexual drive. In women, testosterone is produced by the ovaries (25%), adrenals (25%) and via peripheral conversion from androstenedione (50%). Testerone in women functions to maintain libido and general wellbeing. Testosterone exerts a negative feedback mechanism on pituitary release of LH and follicle-stimulating hormone (FSH). Testosterone may be further converted to dihydrotestosterone or estradiol depending on the tissue. The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. Testosterone is used as hormone replacement or substitution of diminished or absent endogenous testosterone. Use in males: For management of congenital or acquired hypogonadism, hypogonadism associated with HIV infection, and male climacteric (andopause). Use in females: For palliative treatment of androgen-responsive, advanced, inoperable, metastatis (skeletal) carcinoma of the breast in women who are 1-5 years postmenopausal; testosterone esters may be used in combination with estrogens in the management of moderate to severe vasomotor symptoms associated with menopause in women who do not respond to adequately to estrogen therapy alone. — NCATS

Clinical trial activity

453 trials · 332 clinical orgs · 58 marketing orgs

Phase 1
88
Phase 2
227
Phase 3
103
Phase 4
90

Earliest trial started Oct 1, 1992 (NCT00004771)

Timeline

1950s

  1. Dec 24, 1953

    Endo Pharmaceuticals — Earliest FDA Approval

  2. Dec 24, 1953

    Endo Pharmaceuticals — NDA Secondary Org

  3. Dec 24, 1953

    Endo Pharmaceuticals — NDA Organization

1970s

  1. Jul 13, 1972

    Auxillium — Marketing Organization

  2. Dec 3, 1973

    Belmar Pharmacy — Marketing Organization

  3. Jun 23, 1978

    Watson Pharmaceuticals — Marketing Organization

  4. Jul 25, 1979

    Pharmacia & Upjohn — Marketing Organization

  5. Jul 25, 1979

    Pfizer — Marketing Organization

1980s

  1. Jun 13, 1980

    Pharmacia & Upjohn — NDA Secondary Org

  2. Jun 29, 1982

    Savage Labs — Marketing Organization

1990s

  1. Jan 1, 1992

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 1992

    Earliest Phase 3 Sponsor(trial)

  3. Oct 12, 1993

    Alza — NDA Secondary Org

  4. Sep 29, 1995

    Allergan — NDA Secondary Org

  5. Sep 29, 1995

    Allergan — Marketing Organization

2000s

  1. Jan 1, 2000

    Earliest Phase 1 Sponsor(trial)

  2. Feb 28, 2000

    AbbVie — NDA Secondary Org

  3. Feb 28, 2000

    Besins Healthcare — Marketing Organization

  4. Feb 28, 2000

    Besins Healthcare — NDA Secondary Org

  5. Oct 31, 2002

    Auxillium — NDA Secondary Org

  6. Jan 31, 2005

    Paddock Laboratories — Marketing Organization

  7. Jan 31, 2005

    Padagis Us — Marketing Organization

  8. Jan 27, 2006

    Actavis — Marketing Organization

  9. Jun 14, 2006

    Nexus Pharmaceuticals — Marketing Organization

  10. Aug 10, 2006

    Sandoz — Marketing Organization

  11. Aug 10, 2006

    Novartis — Marketing Organization

  12. Dec 11, 2006

    Mylan — Marketing Organization

  13. Dec 11, 2006

    Rising Pharmaceuticals — Marketing Organization

  14. May 23, 2007

    Par Pharmaceuticals — Marketing Organization

  15. May 23, 2007

    Strides Pharma Science — Marketing Organization

2010s

  1. Jul 15, 2010

    Hikma — Marketing Organization

  2. Jul 15, 2010

    West-Ward Pharmaceutical — Marketing Organization

  3. Nov 23, 2010

    Eli Lilly — NDA Secondary Org

  4. Dec 29, 2010

    Bristol-Myers Squibb — NDA Secondary Org

  5. Feb 14, 2012

    Ani Pharmaceuticals — NDA Secondary Org

  6. Jan 31, 2013

    Perrigo — NDA Secondary Org

  7. Jun 3, 2013

    Sun Pharmaceuticals — Marketing Organization

  8. Mar 5, 2014

    Endo Pharmaceuticals — Marketing Organization

  9. May 28, 2014

    AYTU BioScience — NDA Secondary Org

  10. May 28, 2014

    Acerus Pharmaceuticals Corporation — Marketing Organization

  11. May 28, 2014

    Bausch Health Companies — NDA Secondary Org

  12. Jun 4, 2014

    Upsher-Smith Laboratories — NDA Secondary Org

  13. Aug 5, 2015

    Allergan PLC (2015) — Marketing Organization

  14. Jun 16, 2017

    Lutipold — Marketing Organization

  15. Jun 16, 2017

    Sankyo — Marketing Organization

  16. Jun 16, 2017

    Daiichi Sankyo — Marketing Organization

  17. Jul 12, 2017

    Perrigo — Marketing Organization

  18. Oct 23, 2017

    Lupin — Marketing Organization

  19. Jan 29, 2018

    Cipla — Marketing Organization

  20. Sep 28, 2018

    Antares Pharma Inc. — NDA Secondary Org

  21. Mar 27, 2019

    Clarus Therapeutics, Inc. — NDA Secondary Org

  22. Mar 27, 2019

    Clarus Therapeutics, Inc. — Marketing Organization

  23. Mar 27, 2019

    Tolmar Inc. — Marketing Organization

  24. Mar 27, 2019

    Tolmar Inc. — NDA Secondary Org

  25. Apr 10, 2019

    Amneal Pharmaceuticals — Marketing Organization

  26. Apr 10, 2019

    Dr. Reddy's Laboratories — Marketing Organization

  27. Apr 24, 2019

    Wilshire Pharmaceuticals — Marketing Organization

  28. Sep 23, 2019

    TWi Biotechnology, Inc. — Marketing Organization

2020s

  1. Apr 16, 2020

    Exeltis — Marketing Organization

  2. Nov 25, 2020

    Apotex — Marketing Organization

  3. Dec 8, 2020

    Lipocine Inc. — Marketing Organization

  4. Jan 11, 2021

    Dash Pharms — Marketing Organization

  5. Mar 3, 2021

    Alembic — Marketing Organization

  6. Nov 9, 2021

    Encube Ethicals Pvt. Ltd. — Marketing Organization

  7. Mar 28, 2022

    Verity Pharmaceuticals — Marketing Organization

  8. Jun 2, 2022

    Azurity — Marketing Organization

  9. Jun 2, 2022

    Slayback Pharma Llc — Marketing Organization

  10. Jun 2, 2022

    Slayback Pharma Llc — NDA Secondary Org

  11. Jul 27, 2022

    MARIUS PHARMS LLC — Marketing Organization

  12. Jul 27, 2022

    MARIUS PHARMS LLC — NDA Secondary Org

  13. Oct 20, 2023

    Eugia Pharma — Marketing Organization

Indications

Studied for

Mechanism of action

Combination products

  • depo-testadiol

    with estradiol

    Also known as ditate-ds, testosterone cypionate-estradiol cypionate

Approval history

  • approvedPriority reviewDec 24, 1953

Chemistry & pharmacology

Loading structure…

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
Mol. weight
288.4244 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

No

Prodrug

Sources

Also known as

  • 17beta-hydroxy-4-androsten-3-one
  • 17beta-hydroxy-4-androsten-3-one
  • 17beta-testosterone
  • 4-androsten-17β-ol-3-one
  • 4-androsten-17β-ol-3-one
  • abt-slv176
  • abt-slv361
  • andriol
  • andriol
  • andriol
  • andro-cyp
  • andro-cyp
  • androderm
  • androderm
  • androderm
  • androgel
  • androgel
  • androgel 1%
  • androgel 1%
  • andronate
  • andropatch
  • andropatch
  • andropository
  • androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)
  • androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17-beta)-
  • ard-0403
  • axiron
  • axiron
  • btg brand of testosterone enanthate
  • delatestryl
  • delatestryl
  • delatestryl
  • delatestryl
  • depandro
  • depandro
  • deposteron
  • depostomead
  • depotest
  • depotest
  • depo-testadiol
  • depo-testadiol
  • depo-testosterone
  • depo-testosterone
  • depo-testosterone
  • depo-testosterone cypionate
  • duratest
  • durathate
  • eifelfango brand of testosterone enanthate
  • fortesta
  • fortesta
  • intrinsa
  • intrinsa
  • jenapharm brand of testosterone enanthate
  • mertestate
  • mertestate
  • nebido
  • nebido
  • nebido
  • org-538
  • org-538
  • organon brand of testosterone undecanoate
  • pantestone
  • pasadena brand of testosterone enanthate
  • primoteston depot
  • primoteston depot
  • primoteston depot
  • restandol
  • restandol
  • restandol
  • restandol testocap
  • roberts brand of testosterone enanthate
  • rotexmedica brand of testosterone enanthate
  • rugby brand of testosterone enanthate
  • schering brand of testosterone enanthate
  • striant
  • striant
  • striant sr
  • testa-c
  • testex
  • testex
  • testex elmu
  • testim
  • testim
  • testim
  • testim 1%
  • testoderm
  • testoderm
  • testoderm tts
  • testoderm tts
  • testogel
  • testogel
  • testopatch
  • testopel
  • testopel
  • testoral
  • testoral
  • testosteron
  • testosteron
  • testosterona
  • testosterona
  • testosteron-depot eifelfango
  • testosteron-depot jenapharm
  • testosteron depot-rotexmedica
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testosterone
  • testostérone
  • testostérone
  • testosterone 17 beta-cyclopentanepropionate
  • testosterone 17 beta-cyclopentylpropionate
  • testosterone 17 beta-cypionate
  • testosterone cyclopentylpropionate
  • testosterone cyclopentylpropionate
  • testosterone cyclopentylpropionate
  • testosterone cyclopentylpropionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone cypionate
  • testosterone enantate
  • testosterone enantate
  • testosterone enantate
  • testosterone enantate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone enanthate
  • testosterone heptanoate
  • testosterone heptanoate
  • testosterone heptanoate
  • testosterone heptylate
  • testosterone heptylate
  • testosterone oenanthate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone propionate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undecanoate
  • testosterone undeconate
  • testosterone undeconate
  • testosterone undecylate
  • testosterone undecylate
  • testosteronum
  • testosteronum
  • testoviron
  • testoviron
  • testrin p.a.
  • theramed brand of testosterone enanthate
  • theramex
  • tostran
  • tsx-002
  • undestor
  • undestor
  • undestor
  • virormone
  • virormone
  • virormone
  • virormone
  • virormone
  • virormone
  • virosterone
  • virosterone

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07212712N/AMar 1, 2026University of British Columbia
NCT07278362Phase 4Feb 28, 2026University of Miami
NCT07260825Phase 2/Phase 3 (Phase 3)Dec 31, 2025TriHealth
NCT07142551Phase 2Dec 30, 2025Bayer, Johns Hopkins University
NCT07092527Phase 4Dec 1, 2025National Institutes of Health (NIH), University of California, San Diego
NCT07254429Phase 2Oct 2, 2025University of Copenhagen
NCT06922318Phase 2Aug 19, 2025Johns Hopkins University, National Cancer Institute (NCI), Zenith Epigenetics
NCT07028255N/AJul 1, 2025Qualia Life Sciences
NCT07287800Phase 1/Phase 2 (Phase 2)Jul 1, 2025University of California, Los Angeles
NCT06720597N/AJan 31, 2025University of California, Irvine
NCT06689085Phase 3Jan 31, 2025Halozyme Therapeutics
NCT06733350Phase 4Jan 1, 2025State University of New York, Buffalo
NCT06305598Phase 1Dec 15, 2024State University of New York, Buffalo
NCT06450405Phase 4Nov 15, 2024National Institutes of Health (NIH), University of California, San Diego
NCT06592144Phase 4Sep 9, 2024University of Sao Paulo
NCT06188767N/ASep 1, 2024University of Copenhagen
NCT06294990N/AAug 15, 2024University of Copenhagen
NCT06594926Phase 2Aug 14, 2024Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, University of New South Wales
NCT06455969Phase 4Jul 15, 2024United States Army, University of Pittsburgh
NCT06351501Phase 3Jun 6, 2024Assistance Publique - Hôpitaux de Paris
Showing 20 of 453 trials
Page 1 / 23

Organizations

Research & Development (332)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institutes of Health (NIH)Government30551999
University of WashingtonAcademic/Hospital262452002
Harvard UniversityAcademic/Hospital251851998
SolvayFor profit21452002
Department of Veteran AffairsGovernment201451999
Johns Hopkins UniversityAcademic/Hospital161552008
BayerFor profit14432003
Clarus Therapeutics, Inc.For profit141142007
National Institute on Aging (NIA)Government12441999
Acerus Pharmaceuticals CorporationFor profit11842009
National Cancer Institute (NCI)Government10242000
University of California, Los AngelesAcademic/Hospital10442002
MerckFor profit9722001
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government9451998
University of Colorado, DenverAcademic/Hospital9752005
Warner ChilcottFor profit9932002
AbbottFor profit8432007
Boston UniversityAcademic/Hospital8442002
Eli LillyFor profit8842007
Endo PharmaceuticalsFor profit8432006
332 organizations
Page 1 / 17

Marketing (85)

OrganizationOrg typeRelationshipDate
AYTU BioScienceFor profitNDA2May 28, 2014
AbbVieFor profitNDA2Feb 28, 2000
Acerus Pharmaceuticals CorporationFor profitMKTGMay 28, 2014
ActavisFor profitMKTGJan 27, 2006
AlembicFor profitMKTGMar 3, 2021
AlembicFor profitSYNMar 3, 2021
AllerganFor profitNDA2Sep 29, 1995
AllerganFor profitMKTGSep 29, 1995
Allergan PLC (2015)For profitMKTGAug 5, 2015
AlzaFor profitNDA2Oct 12, 1993
Amneal PharmaceuticalsFor profitMKTGApr 10, 2019
Amneal PharmaceuticalsFor profitSYNApr 10, 2019
Ani PharmaceuticalsFor profitNDA2Feb 14, 2012
Ani PharmaceuticalsFor profitSYNFeb 14, 2012
Antares Pharma Inc.For profitNDA2Sep 28, 2018
ApotexFor profitMKTGNov 25, 2020
Athenex, Inc.For profitMKTG
AuxilliumFor profitNDA2Oct 31, 2002
AuxilliumFor profitMKTGJul 13, 1972
AzurityFor profitMKTGJun 2, 2022
Bausch Health CompaniesFor profitNDA2May 28, 2014
Belmar PharmacyFor profitMKTGDec 3, 1973
Besins HealthcareFor profitMKTGFeb 28, 2000
Besins HealthcareFor profitNDA2Feb 28, 2000
Bristol-Myers SquibbFor profitNDA2Dec 29, 2010
CiplaFor profitMKTGJan 29, 2018
Clarus Therapeutics, Inc.For profitNDA2Mar 27, 2019
Clarus Therapeutics, Inc.For profitMKTGMar 27, 2019
Daiichi SankyoFor profitMKTGJun 16, 2017
Dash PharmsFor profitMKTGJan 11, 2021
Dr. Reddy's LaboratoriesFor profitSYNJul 7, 1983
Dr. Reddy's LaboratoriesFor profitMKTGApr 10, 2019
Eli LillyFor profitNDA2Nov 23, 2010
Eli LillyFor profitMKTG
Elkins SinnFor profitMKTG
Encube Ethicals Pvt. Ltd.For profitMKTGNov 9, 2021
Endo PharmaceuticalsFor profitNDA2Dec 24, 1953
Endo PharmaceuticalsFor profitNDADec 24, 1953
Endo PharmaceuticalsFor profitMKTGMar 5, 2014
Endo PharmaceuticalsFor profitSYNJul 13, 1972
Eugia PharmaFor profitMKTGOct 20, 2023
ExeltisFor profitMKTGApr 16, 2020
HikmaFor profitMKTGMay 1, 2012
HikmaFor profitMKTGJul 15, 2010
HikmaFor profitMKTGJul 15, 2010
Lipocine Inc.For profitMKTGDec 8, 2020
LupinFor profitSYNApr 13, 2018
LupinFor profitMKTGOct 23, 2017
LupinFor profitSYNApr 10, 2019
LutipoldFor profitMKTGJun 16, 2017
MARIUS PHARMS LLCFor profitMKTGJul 27, 2022
MARIUS PHARMS LLCFor profitNDA2Jul 27, 2022
MylanFor profitMKTGDec 11, 2006
Nexus PharmaceuticalsFor profitMKTGJun 14, 2006
Nexus PharmaceuticalsFor profitSYNJun 14, 2006
NovartisFor profitMKTGAug 10, 2006
Padagis UsFor profitMKTGAug 4, 2015
Padagis UsFor profitMKTGJan 31, 2005
Paddock LaboratoriesFor profitMKTGJan 31, 2005
Paddock LaboratoriesFor profitSYNDec 9, 2016
Par PharmaceuticalsFor profitMKTGMay 23, 2007
PerrigoFor profitNDA2Jan 31, 2013
PerrigoFor profitMKTGJul 12, 2017
PfizerFor profitMKTGJul 25, 1979
Pharmacia & UpjohnFor profitMKTGJul 25, 1979
Pharmacia & UpjohnFor profitNDA2Jun 13, 1980
Rising PharmaceuticalsFor profitMKTGDec 11, 2006
Rising PharmaceuticalsFor profitSYNDec 11, 2006
SandozFor profitMKTGAug 10, 2006
SandozFor profitSYNAug 10, 2006
SankyoFor profitMKTGJun 16, 2017
Savage LabsFor profitMKTGJun 29, 1982
Slayback Pharma LlcFor profitMKTGJun 2, 2022
Slayback Pharma LlcFor profitNDA2Jun 2, 2022
Strides Pharma ScienceFor profitMKTGMay 23, 2007
Sun PharmaceuticalsFor profitMKTGJun 3, 2013
TWi Biotechnology, Inc.For profitMKTGSep 23, 2019
Tolmar Inc.For profitMKTGMar 27, 2019
Tolmar Inc.For profitNDA2Mar 27, 2019
Upsher-Smith LaboratoriesFor profitNDA2Jun 4, 2014
Verity PharmaceuticalsFor profitMKTGMar 28, 2022
Watson PharmaceuticalsFor profitMKTGJun 23, 1978
Watson PharmaceuticalsFor profitSYNDec 10, 1980
West-Ward PharmaceuticalFor profitMKTGJul 15, 2010
Wilshire PharmaceuticalsFor profitMKTGApr 24, 2019